GlassScriptPhysician profile
Jeffrey A Sorensen
NPI 1578805651
$2,368.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $23.77 · 2021: $531 · 2022: $136 · 2023: $1,037 · 2024: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719 · Travel and Lodging: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.46 |
| Travel and Lodging | $703.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $807.37 | 2023 | Inspire |
| Advanced Bionics, LLC | $461.53 | 2021 | |
| Medtronic, INC. | $241.48 | 2022-2023 | Sinuva |
| Stryker Corporation | $196.94 | 2019-2021 | |
| Smith+Nephew, INC. | $191.74 | 2023-2024 | Tula |
| Livanova USA, INC. | $166.84 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Cochlear Americas | $76.38 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $67.98 | 2019 | |
| Aerin Medical INC. | $55.41 | 2023 | |
| Optinose US, INC. | $28.47 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.85 | 2019 | |
| Intersect Ent, INC. | $26.75 | 2019 | |
| Grifols USA, LLC | $20.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Sorensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.